Tenderwize
Back to tender search

Open house discount agreements for iron(III)hydroxide-polymaltose complex, ATC B03AC01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 260 days left·Open·Supplies·Framework
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eisen(III)hydroxid-Polymaltose-Komplex, ATC B03AC01

50/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No guaranteed purchase volume or minimum order quantity; revenue depends on actual prescriptions and market share.

Open-house agreements may be overridden by future formal framework contracts (bundesweit oder landesspezifisch) for the...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of pharmaceutical products containing iron(III)hydroxide-polymaltose complex (ATC B03AC01) to AOK Bayern insured persons
  • Conclusion of non-exclusive discount agreements (rabattverträge) under §130a(8) SGB V
Show full summary

The AOK Bayern (Bavaria Health Insurance) is conducting an open-house model for non-exclusive discount agreements on pharmaceutical products containing iron(III)hydroxide-polymaltose complex (ATC B03AC01) under §130a(8) SGB V. This is not a typical procurement procedure; any interested pharmaceutical company meeting eligibility criteria can sign identical, non-negotiable agreements. Contracts have a fixed end date of 30 June 2027, with possible start from 1 July 2025. The open-house is open until 5 May 2027. No estimated contract value is provided. The process is governed by German social law, not procurement law. Submission can be in paper form (hand-signed) or electronically with a qualified electronic signature. Only pharmaceutical companies can participate.

Risks

No guaranteed purchase volume or minimum order quantity; revenue depends on actual prescriptions and market share.

Open-house agreements may be overridden by future formal framework contracts (bundesweit oder landesspezifisch) for the...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only pharmaceutical companies (pharmazeutische Unternehmen) can participate

Administrative

  • Submission of signed contract, completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
  • Hand-signed paper documents in duplicate OR electronically with qualified electronic signature via the communication area of the dtvp portal

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; participation is open to all qualified pharmaceutical companies.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house discount agreements for iron(III)hydroxide-polymaltose complex, ATC B03AC01

Non-exclusive discount agreements for the active ingredient iron(III)hydroxide-polymaltose complex (ATC B03AC01). Contracts are identical for all participants, no individual negotiation. Performance location: Bavaria, Germany. Contract period: 1 July 2025 to 30 June 2027. Early termination possible with one month notice. Agreements automatically superseded if a nationwide or state-specific framework discount contract for the same active ingredient is concluded via a formal procedure.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; participation is open to all qualified pharmaceutical companies.

Deadline

Deadline May 05, 2027

Procurement Details

Publication date
15 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
315689-2025

Documents (2)

Procurement document 1Submission portal 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24